Gan&Lee | Briefing, News, Analysis, Research, Data

Gan&Lee

Gan&Lee is a high-tech biopharmaceutical enterprise integrating research

Gan & Lee Pharmaceutical Co., Ltd. was established in 1998, is a high-tech biopharmaceutical enterprise integrating research, development, production and sales. The company is a leading company at home and abroad in the development, research and production of biosynthetic human insulin and its analogs, and is a professional company focusing on biosynthetic human insulin analogs.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Founded

Jun 1, 1998

HQ location

Beijing, China

Legal name

Beijing Gan & Lee Biotechnology Co., Ltd.

Website

http://www.ganlee.com/

jianjun.gan@ganlee.com

Employees

1001-5000

All
News
Analysis
Research

Briefing Feb 16, 2023 12:51 PM · Healthcare

Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A

Briefing Jun 22, 2022 04:19 PM · Technology | Consumer Discretionary | Healthcare

Zhaolihong, former member of the Party committee and vice president of Agricultural Bank of China Hebei Branch, was "double opened"

In-depth

Healthcare

Chinese Company Turned the Tables on Domestic Cell Culture Media Market

In this article, EqualOcean mainly introduce the history, competition, lead company, future trend in domestic cell culture media industry.

Feb 02, 2023 10:45 AM

Briefing Mar 10, 2022 03:49 PM · Technology | Consumer Staples | Healthcare

Liaoning Province held a working meeting to promote the listing of enterprises and launched the doubling plan for the listing of enterprises

Briefing Feb 23, 2022 06:59 PM · Technology | Healthcare | Financials

Pioneer fund welcomes the new general manager and the executive deputy general manager will no longer act as the general manager

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Technology, Healthcare, Financials

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Briefing Dec 10, 2021 05:49 PM · Technology | Consumer Staples | Consumer Discretionary

Haipurui: it plans to publicly issue corporate bonds of no more than RMB 1.5 billion to professional investors

Briefing Dec 06, 2021 04:49 PM · Technology | Consumer Staples | Healthcare

Humon shares: the 2021 ESOP has not yet started to purchase the company's shares

Briefing Nov 30, 2021 04:09 PM · Technology | Consumer Staples | Healthcare

Stellar Technology: 34.6 million shares pledged and extended by the controlling shareholder

Briefing Nov 26, 2021 11:38 AM · Healthcare

Ganli pharmaceutical won the bid for centralized procurement of insulin glargine injection

Healthcare

HealthGuard: Registration of Indonesian Subsidiary, Investment in Producing HPV Vaccine

Jun 20, 2024 03:12 PM

Healthcare

SINOVAC Plans to Invest USD 100 Mn in Brazil Starting This Year

EqualOcean has learned that on June 4, Vice President of the Federative Republic of Brazil and Minister of Development, Industry, Trade, and Services, Geraldo Alckmin, met with SINOVAC(科兴) Chairman, President, and CEO Yin Weidong(尹卫东) in Beijing.

Jun 06, 2024 06:18 PM

Briefing Nov 26, 2021 11:30 AM

Special national collection of insulin: Ganli pharmaceutical Ganjing and asparagus insulin all reported the lowest prices: 48.71 yuan and 19.98 yuan

Briefing Nov 17, 2021 06:49 PM

Robin Li: Baidu has become the world's largest automated driving service provider.

Briefing Oct 12, 2021 05:23 PM · Technology | Healthcare | Automotive

Urban investment holding: the newly signed amount of real estate projects in the third quarter was about 304.3 million yuan

Healthcare

Yilite Technology Completes A+ Round Financing of CNY 100 Million

Yilite Technology has secured over CNY 100 million in two rounds of financing within the year.

May 15, 2024 03:21 PM

Healthcare

Cellatopia Secures Nearly CNY Ten Mn in Seed Funding

EqualOcean has learned that Cellatopia(喜同生物), a biotechnology company based in Suzhou, recently announced the successful securing of nearly CNY ten million in seed funding. The funding was primarily led by Suzhou Shishangbai Venture Capital(苏州石上柏创业合伙企业) and followed by institutions such as Suzhou Nuowei Venture Investment Limited(苏州诺为创业投资有限公司).

Apr 18, 2024 01:25 PM

Briefing Sep 10, 2021 06:57 PM · Technology | Healthcare | Financials

Xin Guobin: accelerate the promotion of robots such as family services, education and entertainment

Briefing Aug 24, 2021 05:28 PM · Technology | Consumer Staples | Healthcare

Huitai medical: net profit in the first half of the year increased by 186.24% year-on-year

Briefing Aug 20, 2021 05:48 PM · Healthcare

During the 14th Five Year Plan period, China will restore 230 million mu of degraded grassland

Briefing Jul 23, 2021 10:13 AM · Healthcare

Pharmaceutical and biological stocks fell sharply in early trading

EqualOcean Analysis